Litigation Details for AbbVie Inc. v. Prinston Pharmaceutical Inc. (D. Del. 2023)
✉ Email this page to a colleague
AbbVie Inc. v. Prinston Pharmaceutical Inc. (D. Del. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-06-02 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
Jury Demand | None | Referred To | |
Patents | 10,537,572; 7,056,927; 7,419,983 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AbbVie Inc. v. Prinston Pharmaceutical Inc.
Details for AbbVie Inc. v. Prinston Pharmaceutical Inc. (D. Del. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-08-16 | 14 | Order | the expiration of U.S. Patent Nos. 7,056,927, 7,716,211, 7,419,983, 10,537,572, 10,682,351, and/or 11,344,551… States prior to the expiration of U.S. Patent Nos. 10,537,572, 10,682,351, and/or 11,542,239: C.A. Nos… 2 June 2023 1:23-cv-00607 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |